Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.

[1]  F. Cunha,et al.  Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[2]  Yan Chen,et al.  Ameloblastic fibroma: a review of published studies with special reference to its nature and biological behavior. , 2007, Oral oncology.

[3]  M. Amirchaghmaghi,et al.  Extension of Pindborg tumor to the maxillary sinus: a case report. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  N. Bostanci,et al.  Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. , 2007, Microbial pathogenesis.

[5]  E. Raubenheimer,et al.  Odontogenic myxoma: review of the literature and report of 30 cases from South Africa. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  I. Koutlas,et al.  Expression of OPG, RANKL, and Trail in Odontogenic Keratocysts (OKC): An Immunohistochemical Study , 2007 .

[7]  J. Granjeiro,et al.  Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  W. Carpenter,et al.  Relative frequency of central odontogenic tumors: a study of 1,088 cases from Northern California and comparison to studies from other parts of the world. , 2006, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[9]  Adam V. Jones,et al.  An analysis of oral and maxillofacial pathology found in adults over a 30-year period. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  N. Dutzan,et al.  RANKL in human periapical granuloma: possible involvement in periapical bone destruction. , 2006, Oral diseases.

[11]  Seiji Nakamura,et al.  Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas. , 2006, Oral oncology.

[12]  R. Mesquita,et al.  Odontogenic tumors: a study of 340 cases in a Brazilian population. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[13]  S. Vastardis,et al.  Management of an unusually large adenomatoid odontogenic tumor , 2005 .

[14]  H. Takayanagi.  Inflammatory bone destruction and osteoimmunology. , 2005, Journal of periodontal research.

[15]  P. Miossec,et al.  RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. , 2005, Arthritis and rheumatism.

[16]  T. Kukita,et al.  Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. , 2005, Oral oncology.

[17]  D. Isaza-Guzmán,et al.  Immunohistochemical expression of RANK, GRalpha and CTR in central giant cell granuloma of the jaws. , 2005, Oral oncology.

[18]  M. Padrines,et al.  RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. , 2004, Biochimica et biophysica acta.

[19]  B. Bay,et al.  Identification of RANKL in Osteolytic Lesions of the Facial Skeleton , 2004, Journal of dental research.

[20]  U. Lerner.  NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION. , 2004, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[21]  Kwan Tat Steeve,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .

[22]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[23]  Shi-feng Yu,et al.  Clinicopathologic Spectrum of the So-Called Calcifying Odontogenic Cysts: A Study of 21 Intraosseous Cases With Reconsideration of the Terminology and Classification , 2003, The American journal of surgical pathology.

[24]  J. Regezi.  Odontogenic Cysts, Odontogenic Tumors, Fibroosseous, and Giant Cell Lesions of the Jaws , 2002, Modern Pathology.

[25]  S. Khosla,et al.  Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.

[26]  G. Wise,et al.  Osteoprotegerin and Osteoclast Differentiation Factor in Tooth Eruption , 2000, Journal of dental research.

[27]  C. Rani,et al.  Dental cells express factors that regulate bone resorption. , 2000, Molecular cell biology research communications : MCBRC.

[28]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[29]  D. Macdonald,et al.  Adenomatoid odontogenic tumour. A survey of 21 cases from Sri Lanka. , 1990, International journal of oral and maxillofacial surgery.

[30]  Wei Tang,et al.  Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. , 2007, International journal of oral and maxillofacial surgery.

[31]  Teiji Wada,et al.  RANKL-RANK signaling in osteoclastogenesis and bone disease. , 2006, Trends in molecular medicine.

[32]  L. Barnes,et al.  Pathology and genetics of head and neck tumours , 2005 .

[33]  H. Kumamoto,et al.  Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.